These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. Neufeld AH; Das S; Vora S; Gachie E; Kawai S; Manning PT; Connor JR J Glaucoma; 2002 Jun; 11(3):221-5. PubMed ID: 12140399 [TBL] [Abstract][Full Text] [Related]
7. [Neuroprotection in glaucoma. What is the current status?]. Haefliger IO; Pellanda N; Fleischhauer JC; Gekkieva M; Flammer J Ophthalmologe; 2001 Jun; 98(6):564-7. PubMed ID: 11450482 [No Abstract] [Full Text] [Related]
8. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC; Waxman SG Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495 [TBL] [Abstract][Full Text] [Related]
9. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy. Hartwick AT Optom Vis Sci; 2001 Feb; 78(2):85-94. PubMed ID: 11265931 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165 [TBL] [Abstract][Full Text] [Related]
12. Saving the nerve from glaucoma: memantine to caspaces. Naskar R; Vorwerk CK; Dreyer EB Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579 [TBL] [Abstract][Full Text] [Related]
13. [The option of neuroprotective therapeutics for glaucoma]. Xiong S; Xu X Zhonghua Yan Ke Za Zhi; 2014 Aug; 50(8):630-3. PubMed ID: 25385383 [TBL] [Abstract][Full Text] [Related]
14. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135 [TBL] [Abstract][Full Text] [Related]
16. Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma. Yanagisawa M; Aida T; Takeda T; Namekata K; Harada T; Shinagawa R; Tanaka K Cell Death Dis; 2015 Mar; 6(3):e1693. PubMed ID: 25789968 [TBL] [Abstract][Full Text] [Related]
17. Melatonin: a novel neuroprotectant for the treatment of glaucoma. Belforte NA; Moreno MC; de Zavalía N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE J Pineal Res; 2010 May; 48(4):353-64. PubMed ID: 20374442 [TBL] [Abstract][Full Text] [Related]
18. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471 [TBL] [Abstract][Full Text] [Related]
19. [Prospects for neuroprotective glaucoma therapy]. Grehn F Ophthalmologe; 2001 Oct; 98(10):925-8. PubMed ID: 11699312 [No Abstract] [Full Text] [Related]
20. Neuroprotective Strategies in Glaucoma. Gossman CA; Christie J; Webster MK; Linn DM; Linn CL Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]